Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00912509 · ClinicalTrials.gov registry record · NA
Cross Linking for Treatment of Corneal Infection
A NA study, sponsored by Price Vision Group.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00912509: Clinical Trial NA study, sponsored by Price Vision Group.
NCT00912509 is a NA study that was terminated before completion, run by Price Vision Group. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00912509, a NA study, was terminated before completion, sponsored by Price Vision Group.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study is comparing 45 minute and 30 minute treatment durations with the UVX corneal cross linking system to treat corneal infections.
Interventions
- DRUG riboflavin
- DEVICE UVX Light
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-05 |
| Est. Completion | 2013-06 |
| Phase | NA |
Why NCT00912509 stopped before completion
NCT00912509 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which riboflavin is the first listed.
NCT00912509 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00912509 about?
NCT00912509 is a clinical study titled "Cross Linking for Treatment of Corneal Infection". This study is comparing 45 minute and 30 minute treatment durations with the UVX corneal cross linking system to treat corneal infections.
What is the current status of trial NCT00912509?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2009-05. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00912509?
The interventions under investigation include: riboflavin (DRUG), UVX Light (DEVICE).
Who is sponsoring clinical trial NCT00912509?
This trial is sponsored by Price Vision Group, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00912509's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia